Calidi Biotherapeutics, Inc. (CLDI)
AMEX·Healthcare·Biotechnology
$0.69
+4.39%
Mkt Cap $2.62M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$5.50
Range $2.00 – $9.00
Implied Upside
+698.3%
Consensus $5.50 vs current $0.69
AMEX·Healthcare·Biotechnology
$0.69
+4.39%
Mkt Cap $2.62M
No recent rating data.
Price Target (2 analysts)
$5.50
Range $2.00 – $9.00
+698.3%
Consensus $5.50 vs current $0.69